Immunohistochemical versus molecular (BluePrint and MammaPrint) subtyping of breast carcinoma. Outcome results from the EORTC 10041/BIG 3-04 MINDACT trial von Viale, G., de Snoo, F. A., Slaets, L., Bogaerts, J., van ’t Veer, L., Rutgers, E. J., Piccart-Gebhart, M. J., Stork-Sloots, L., Glas, A., Russo, L., Dell’Orto, P., Tryfonidis, K., Litière, S., Cardoso, F.

Volltext

High concordance of protein (by IHC), gene (by FISH; HER2 only), and microarray readout (by TargetPrint) of ER, PgR, and HER2: results from the EORTC 10041/BIG 03-04 MINDACT trial von Viale, G., Slaets, L., Bogaerts, J., Rutgers, E., van't Veer, L., Piccart-Gebhart, M.J., de Snoo, F.A., Stork-Sloots, L., Russo, L., Dell'Orto, P., van den Akker, J., Glas, A., Cardoso, F.

Volltext

Gene expression profiling to predict the risk of locoregional recurrence in breast cancer: a pooled analysis von Drukker, C. A., Elias, S. G., Nijenhuis, M. V., Wesseling, J., Bartelink, H., Elkhuizen, P., Fowble, B., Whitworth, P. W., Patel, R. R., de Snoo, F. A., van ’t Veer, L. J., Beitsch, P. D., Rutgers, E. J. Th

Volltext

Hereditary melanoma and predictive genetic testing: why not? von Riedijk, S.R., de Snoo, F.A., van Dijk, S., Bergman, W., van Haeringen, A., Silberg, S., van Elderen, T.M.T., Tibben, A.

Volltext

Iatrogenic melanoma. Comment on: Melanoma epidemic: a midsummer night's dream? von Van Der Rhee, J.I., Mooi, W.J., Kukutsch, N.A., De Snoo, F.A., Bergman, W.

Volltext

European inter-institutional impact study of MammaPrint von Cusumano, P.G, Generali, D, Ciruelos, E, Manso, L, Ghanem, I, Lifrange, E, Jerusalem, G, Klaase, J, de Snoo, F, Stork-Sloots, L, Dekker-Vroling, L, Holzik, M. Lutke

Volltext

Erratum to: Gene expression profiling to predict the risk of locoregional recurrence in breast cancer: a pooled analysis von Drukker, C. A., Elias, S. G., Nijenhuis, M. V., Wesseling, J., Bartelink, H., Elkhuizen, P., Fowble, B., Whitworth, P. W., Patel, R. R., de Snoo, F. A., van’t Veer, L. J., Beitsch, P. D., Rutgers, E. J. Th

Volltext

MT37 Clinical Utility of Circulating Tumor Cell (CTC) Enumeration-Based Liquid Biopsy and HER2 CTC Assessment in Patients with Metastatic Breast Cancer: Overview of Current Availab... von Cristofanilli, M., de Snoo, F., Stork-Sloots, L., Hansen, T., Garay, C.A., Lazaro, S., Chabut, D., Picardo, F., Warren-Mora, N., Kuhr, F., Spinner, D.

Volltext

MT21 Clinical Application of Circulating Tumor Cells in Melanoma Patients: Overview of Current Available Data von de Snoo, F., Lucci, A., Spinner, D., Stork-Sloots, L., Chabut, D., Picardo, F., Warren-Mora, N., Lazaro, S., Kuhr, F.

Volltext

CO119 Clinical Utility of Circulating Tumor Cell Enumeration-Based Liquid Biopsy in Patients with Metastatic Breast Cancer: A Review of the Peer-Reviewed Clinical Literature von Cristofanilli, M., de Snoo, F., Stork-Sloots, L., Hansen, T., Garay, C.A., Lazaro, S., Chabut, D., Picardo, F., Simonelli, C., Kuhr, F., Spinner, D.

Volltext

P204 Microarray based determination of ER, PR and HER2 receptor status compared to local ICH/FISH assessment in 641 patients von Cusumano, G, Guinebretiere, J, Seitz, G, Watanabe, T, Palacios, J, De Snoo, F, Sapino, A

Volltext

0075 Use of the genomic test MammaPrint in daily clinical practice to assist in risk stratification of young breast cancer patients von Kunz, G, Glas, A, de Snoo, F, Simon, I

Volltext

117 Development and validation of an array based Molecular Subtyping Profile for breast cancer von de Snoo, F, Roepman, P, Glas, A

Volltext

Microarray analysis as a helpful tool in identifying the primary tumour in cancer with an unknown primary site von Soesan, M, de Snoo, F, Westerga, J, Floore, A, Bender, R

Volltext

260PDCHEMOSENSITIVITY PREDICTED BY MAMMAPRINT AND BLUEPRINT IN THE PROSPECTIVE NEO-ADJUVANT BREAST REGISTRY SYMPHONY TRIAL (NBRST) von De Snoo, F., Whitworth, P., Stork-Sloots, L., Beitsch, P.

Volltext

Chemosensitivity Predicted By Mammaprint and Blueprint in the Prospective Neo-Adjuvant Breast Registry Symphony Trial (Nbrst) von De Snoo, F., Whitworth, P., Stork-Sloots, L., Beitsch, P.

Volltext

0063 Comparison of MammaPrint and TargetPrint results with clinical parameters in German patients (PATH) with early stage breast cancer von Kunz, G, Dimpfl, T, Jakisch, C, Buttner, R, de Snoo, F, Krijgsman, O, van Lienen, E, Glas, A, Bender, R

Volltext

Not all small node negative (pT1abN0) breast cancers are similar: Outcome results from an EORTC 10041/BIG 3-04 (MINDACT) trial substudy von Tryfonidis, K., Poncet, C., Slaets, L., Viale, G., de Snoo, F., Aalders, K., Van 't Veer, L., Rutgers, E., Piccart, M., Bogaerts, J., Cardoso, F.

Volltext

Immunohistochemical versus molecular von Viale, G, Piccart-Gebhart, M. J, Rutgers, E. J, Slaets, L, van 't Veer, L, de Snoo, F. A, Bogaerts, J

Volltext

0074 Early prognosis prediction: MammaPrint on core-needle biopsies von de Snoo, F, Glas, A, Floore, A, Mayordomo, J, Modollel, A, Rolfo, C, van 't Veer, L, Rutgers, E, Rodenhuis, S, Bender, R

Volltext